These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38091826)
1. CD4 Huang Y; Huang X; Wei Z; Dong J; Lu J; Tang Q; Lu F; Cen Z; Wu W Int Immunopharmacol; 2024 Jan; 127():111304. PubMed ID: 38091826 [TBL] [Abstract][Full Text] [Related]
2. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis. Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q Virol J; 2014 Dec; 11():230. PubMed ID: 25547181 [TBL] [Abstract][Full Text] [Related]
3. Low-dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice. Nyland JF; Fairweather D; Shirley DL; Davis SE; Rose NR; Silbergeld EK Toxicol Sci; 2012 Jan; 125(1):134-43. PubMed ID: 21984480 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy. Seko Y; Yamazaki T; Shinkai Y; Yagita H; Okumura K; Naito S; Imataka K; Fujii J; Yazaki Y Jpn Circ J; 1992 Oct; 56(10):1062-72. PubMed ID: 1331556 [TBL] [Abstract][Full Text] [Related]
7. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy. Massilamany C; Gangaplara A; Reddy J Int J Cardiol; 2014 Dec; 177(2):330-339. PubMed ID: 25449464 [TBL] [Abstract][Full Text] [Related]
8. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status. Leipner C; Grün K; Borchers M; Stelzner A Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy. Huber SA; Budd RC; Rossner K; Newell MK Ann N Y Acad Sci; 1999; 887():181-90. PubMed ID: 10668474 [TBL] [Abstract][Full Text] [Related]
10. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis. Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858 [TBL] [Abstract][Full Text] [Related]
12. In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy. Xie Y; Li M; Wang X; Zhang X; Peng T; Yang Y; Zou Y; Ge J; Chen H; Chen R PLoS One; 2013; 8(8):e72158. PubMed ID: 23977238 [TBL] [Abstract][Full Text] [Related]
13. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. Huber SA; Sartini D; Exley M J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321 [TBL] [Abstract][Full Text] [Related]
14. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210 [TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Huber SA Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288 [TBL] [Abstract][Full Text] [Related]
16. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4. Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589 [TBL] [Abstract][Full Text] [Related]
17. NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy. Kong Q; Gu J; Lu R; Huang C; Hu X; Wu W; Lin D Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053260 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Cihakova D; Barin JG; Afanasyeva M; Kimura M; Fairweather D; Berg M; Talor MV; Baldeviano GC; Frisancho S; Gabrielson K; Bedja D; Rose NR Am J Pathol; 2008 May; 172(5):1195-208. PubMed ID: 18403598 [TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. Cao Y; Xu W; Xiong S PLoS One; 2013; 8(9):e74955. PubMed ID: 24023968 [TBL] [Abstract][Full Text] [Related]
20. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Coronado MJ; Brandt JE; Kim E; Bucek A; Bedja D; Abston ED; Shin J; Gabrielson KL; Mitzner W; Fairweather D Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1726-36. PubMed ID: 22328081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]